Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors

Anaïs Oudin*, Virginie Baus, Vanessa Barthelemy, Carina Fabian, Eliane Klein, Monika Dieterle, May Wantz, Ann Christin Hau, Claire Dording, Amandine Bernard, Alessandro Michelucci, Yahaya A. Yabo, Georgia Kanli, Olivier Keunen, Rolf Bjerkvig, Simone P. Niclou, Anna Golebiewska

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Tumor organoids and patient-derived orthotopic xenografts (PDOXs) are some of the most valuable pre-clinical tools in cancer research. In this protocol, we describe efficient derivation of organoids and PDOX models from glioma patient tumors. We provide detailed steps for organoid culture, intracranial implantation, and detection of tumors in the brain. We further present technical adjustments for standardized functional assays and drug testing. For complete details on the use and execution of this protocol, please refer to Golebiewska et al. (2020).

Original languageEnglish
Article number100534
Pages (from-to)100534
JournalSTAR Protocols
Volume2
Issue number2
DOIs
Publication statusPublished - 18 Jun 2021

Keywords

  • Cancer
  • Cell Biology
  • Cell culture
  • Cell isolation
  • Model Organisms
  • Neuroscience
  • Organoids

Fingerprint

Dive into the research topics of 'Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors'. Together they form a unique fingerprint.

Cite this